Aquinox Pharma (AQXP) Reports FY Loss of $1.96
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cantor Fitzgerald Reiterates Overweight on Aquinox Pharma (AQXP) Following 4Q
March 10, 2017 7:53 AM ESTCantor Fitzgerald reiterated an Overweight rating and $28.00 price target on Aquinox Pharmaceutical (NASDAQ: AQXP) following 4Q earnings report. QXP reported cash of $153.1 million as compared to $162.6 million at 3Q16, representing a cash burn of $9.5 million for the quarter and $31 million for the year.... More
